The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
Open Access
- 4 March 2017
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 5 (1) , 10
Abstract
Oncolytic virotherapy represents a novel therapeutic strategy in the treatment of gastrointestinal malignancies. Oncolytic viruses, including genetically engineered and naturally occurring viruses, can selectively replicate in and induce tumor cell apoptosis without harming normal tissues, thus offering a promising tool in the armamentarium for cancer therapy. While this approach has garnered much interest over the past several decades, there has not been significant headway across various tumor types. The recent approval of talimogene laherparepvec, a second-generation oncolytic herpes simplex virus type-1, for the treatment of metastatic melanoma, confirms the therapeutic potential of oncolytic viral therapy. Herein, we will highlight and review the role of oncolytic viral therapy in gastrointestinal malignancies while discussing its limitations and potential alternative mechanisms to improve its treatment efficacy.Keywords
This publication has 72 references indexed in Scilit:
- Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancerCell Death & Disease, 2013
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal AdenocarcinomaJournal of Virology, 2012
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses CollideMolecular Therapy, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman PrimatesHuman Gene Therapy, 2010
- Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumorCancer Gene Therapy, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Negative Regulation of the Alpha Interferon-Induced Antiviral Response by the Ras/Raf/MEK PathwayJournal of Virology, 2006